NEW YORK CITY, New York: At the start of 2025, drug companies raised prices on over 250 brand-name medications in the U.S., including Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's ...
Lupin has gained tentative approval from the Food and Drug Administration for abacavir, dolutegravir and lamivudine tablets for oral suspension, 60 mg/5 mg/30 mg, which is a generic of ViiV ...